Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Blood|November 1, 1990
All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationshipC Chomienne, P Ballerini, N Balitrand, et al.Oncogene|January 11, 2007
Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cellsA Cras, D Darsin-Bettinger, N Balitrand, et al.Nature Medicine|June 17, 1999
Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemiaR S Charrad, Y Li, B Delpech, et al.Molecular and Cellular Biology|September 22, 1999
Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complexL Delva, J N Bastie, C Rochette-Egly, et al.Leukemia|January 1, 1996
All-trans retinoic acid rapidly decreases cathepsin G synthesis and mRNA expression in acute promyelocytic leukemiaJ Seale, L Delva, P Renesto, et al.Leukemia|February 16, 2000
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCRB Cassinat, F Zassadowski, N Balitrand, et al.Blood|October 25, 2001
In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcomeB Cassinat, S Chevret, F Zassadowski, et al.Blood|October 1, 1993
Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cellsL Delva, M Cornic, N Balitrand, et al.Leukemia|February 1, 1994
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patientF Guidez, W Huang, J H Tong, et al.Blood|June 1, 1994
Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cellsC Dubois, M H Schlageter, A de Gentile, et al.Pageof 5